Heritability and candidate genes in tobacco use;Héritabilité et gènes candidats dans le tabagisme

Encephale

Volumn 32, Issue 6, 2006, Pages 966-975

  Hamdani, N ^a,b   Ades, J ^b   Gorwood, P ^b  

^a INSERM   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

Candidate genes; Heritability; Pharmacogenetics; Tobacco use

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2A6; CYTOCHROME P450 2D6; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; NICOTINE; SEROTONIN TRANSPORTER;

ADOPTION; ALCOHOL ABUSE; ANXIETY; ATTENTION; BIOAVAILABILITY; BRAIN; CLINICAL FEATURE; COFFEE; DEPRESSION; DOPAMINERGIC TRANSMISSION; ENZYME METABOLISM; GENDER; GENE; GENETIC POLYMORPHISM; GENETICS; HEREDITY; HERITABILITY; HIGH RISK POPULATION; HUMAN; LIFESPAN; LIMBIC SYSTEM; MOLECULAR GENETICS; NEUROMODULATION; NEUROTRANSMISSION; ONSET AGE; PATHOPHYSIOLOGY; REINFORCEMENT; REVIEW; SMOKING; TEMPERAMENT; TOBACCO; TOBACCO DEPENDENCE; TWINS; ARTICLE; GENETIC ANALYSIS; GENETIC ASSOCIATION; PHARMACOGENETICS; RESEARCH; TREATMENT PLANNING;

EID: 33845968531     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0013-7006(06)76275-3     Document Type: Article

References (85)

1. ASCHER J, COLES J, COLIN J. Bupropion : a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995 ; 56 : 395-401.
2. ANOKHIN AP, TODOROV AA, MADDEN PA et al. Brain event-related potentials, dopamine D2 receptor gene polymorphism, and smoking. Genet Epidemiol 1999 ; 17 (Suppl1) : S37-42.
3. ARINAMI T, OHTSUKI T, YAMAKAWA-KOBAKASHI K et al. A synergistic effect of seotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999 ; 81 : 853-6.
4. BALFOUR DJ. The pharmacology underlying pharmacotherapy for tobacco dependence : a focus on bupropion. Int J Clin Pract 2001 ; 55 (1) : 53-7.
5. BENJAMIN J, LI L, PATTERSON C et al. Population and familial association between the D4 dopamine receptor gene and mesures of novelty seeking. Nat Genet 1996 ; 12 : 81-4.
6. BERTILSSON L, LOU YQ, DU YL et al. Pronounced differences in native Chinese and Sweddish populations in the polymorphic hydroxylations of desibroquin and S-mephenytoin. Clin Pharmacol Ther 1992 ; 51 : 388-97.
7. BOOSMA DI, KOOPMANS JR, LORENZ JP et al. Genetic and social influence on starting to smoke : a study of Dutch adolescent twins and their parents. Addiction 1994 ; 89 : 219-26.
8. CARMELLI D, SWAN GE, ROBINETTE D et al. Genetic influence on smoking- a study of male twins. N Engl J Med 1992 ; 327 : 881-3.
9. CHECKOWAY H, FRANKLIN GM, COSTA-MALLEA P et al. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology 1998 ; 50 : 1458-61.
10. CHENG LS, SWAN GE, CARMELLI D. A genetic analysis of smoking behavior in family members of older adult males. Addiction 2000 ; 95 (3) : 427-35.
11. CLARK DB, KIRISCI L, MOSS HB. Early adolescent gateway drug use in sons of fathers with substance use disorders. Addict Behav 1998 ; 23 (4) : 561-6.
12. COMINGS DE, FERRY L, BRADSHAW-ROBINSON S et al. The dopamine D2 receptor gene : a genetic risk factor in smoking. Pharmacogenetics 1996 ; 6 : 73-9.
13. COMINGS DE, GADE R, WU S et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 1997 ; 2 : 44-56.
14. COMINGS DE, WU S, GONZALEZ N et al. Cholecystokinin (CCK) gene as a possible risk factor for smoking : a replication in two independent samples. Mol Genet Metab 2001 ; 73 : 349-53.
15. DANI JA. Roles of dopamine signaling in nicotine addiction. Mol Psychiatry 2003 ; 8 : 255-6.
16. DAVID S, NIAURA R, PAPANDONATOS G et al. Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome ? Nicotine Tob Res 2003 ; 5 (6) : 935-42.
17. DEVEREUX TR, TAYLOR JA, BARRET JC. Molecular mechanisms of lung cancer : interaction of environemental and genetic factor. Chest 1996 ; 109 : 14S-19S.
18. DIFRANZA JR, SAVAGEAU JA, FLETCHER K et al. Recollections and repercussions of the first inhaled cigarette. Addict Behav 2004 ; 29 (2) : 261-72.
19. DO PRADO-LIMA PA, CHATKIN JM, TAUFER M et al. Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am J Med Genet B Neuropsychiatr Genet 2004 ; 128 (1) : 90-3.
20. DUGGIRALA R, ALMASY L, BLANGERO J. Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genet Epidemiol 1999 ; 17 (Suppl 1) : S139-44.
21. FENG Y, NIU T, XING H et al. A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 2004 ; 75 (1) : 112-21.
22. FERNANDEZ-SALGUERO P, GONZALEZ FJ. The CYP2A gene subfamily : species, differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics 1995 ; 5 : S123-8.
23. FIORE M, NOVOTNY T, PIERCE J et al. Methods use to quit smoking in the United States. Do cessation programs help ? JAMA 1990 ; 263 : 2760-5.
24. FISHER RA. Cigarettes, cancer and statistics. Centen Rev 1958 ; 2 : 151-66.
25. GELERNTER J, LIU X, HESSELBROCK V et al. Results of a genomewide linkage scan : support for chromosomes 9 and 11 loci increasing risk for cigarette smoking. Am J Med Genet B Neuropsychiatr Genet 2004 ; 128 (1) : 94-101.
26. GERACIOTI TD, WEST JR, BAKER SA. Low CSF concentration of dopamine metabolite in tobacco smokers. Am J Psychiatry 1999 ; 156 : 130-2.
27. GOODMAN A. Sexual Addiction. An integrated approch. Madison, Connecticut : International Universities Press Inc, 1998.
28. GOUGH AC, SMITH CA, HOWELL SM et al. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridation, and linkage analysis. Genomics 1993 ; 15 : 430-2.
29. GU DF, HINKS LJ, MORTON NE et al. The use of long PCR to confirm three common alleles at the CYP2A6 locus and relationship between genotype and smoking habit. Ann Hum Genet 2000 ; 64 : 383-90.
30. HAN C, MC GUE MK, IACONO WG. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins : univariate and multivariate behavioral genetic analyses. Addiction 1999 ; 94 (7) : 981-93.
31. HEATH AC, KENDLER KS, EAVES LJ et al. The resolution of biological and cultural inheritance : informativeness of different relationships. Behav Genet 1985 ; 23 : 29-50.
32. HEATH AC, MARTIN NG. Genetic models for the natural history of smoking : evidence for a genetic influence on smoking persistence. Add Behav 1993 ; 18 : 19-34.
33. HEINZ A, GOLDMAN D, JONES DW et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000 ; 22 : 133-9.
34. HOPFER CJ, STALLINGS MC, HEWITT JK. Common genetic and environnemental vulnerability for alcohol and tobacco use in a volunteer sample of older female twins. J Stud Alcohol 2001 : 717-22.
35. HU S, BRODY CL, FISHER C et al. Interaction between the transporter serotonin gene and neuroticism in cigarette smoking behavior. Mol Psychiatry 2000 ; 5 : 181-8.
36. ISHIKAWA H, OHTSUKI T, ISHIGURO H et al. Association between serotonin transporter gene and smoking among Japanese males. Cancer Epidemiol Biomark Prev 1999 ; 8 : 831-3.
37. JONSSON EG, NOTHEN MM, GRUNHAGE F et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999 ; 4 (3) : 290-6.
38. KAPRIO J, KOSKENVUO M, LANGINVIANO H. Finnish twins reared apart, IV : smoking and drinking habits : a preliminary analysis of the effect of heredity and environnement. Acta Med Gemellol (Roma) 1984 ; 33 : 425-33.
39. KENDLER KS, THORNTON LM, PEDERSEN NL. Tobacco consumption in Swedish twins reared apart and reared together. Arch Gen Psychiatry 2000 ; 57 (9) : 886-92.
40. KOOPMANS JR, SLUTSKE WS, HEATH AC et al. The genetics of smoking initiation and quantity smoked in Dutch adolescent and young adult twins. Behav Genet 1999 ; 29 (6) : 383-93.
41. LERMAN C, CAPOROSO NE, AUDRAIN J et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999 ; 18 : 14-20.
42. LERMAN C, CAPOROSO NE, AUDRAIN J et al. Interaction effect of the serotonin transporter gene and neuroticism in cigarette smoking behaviour. Mol Psychiatry 2000 ; 5 : 189-92.
43. LERMAN C, SHIELDS PG, WILEYTO EP et al. Pharmacogenetic investigation of smoking cessation treatment. Pharmacogenetics 2002 ; 12 (8) : 627-34.
44. LI MD, MA JZ, CHENG R, DUPONT RT et al. A genome-wide scan to identify loci for smoking rate in the Framingham Heart Study population. BMC Genet 2003 ; 31 (Suppl 1) : S103.
45. McGUE M, ELKINS I, IACONO WG. Genetic and environnemental influences on adolescent substance use and abuse. Am J Med Genet 2000 ; 96 : 671-77.
46. McKINNEY EF, WALTON RT, YUDKIN P et al. Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000 ; 10 : 483-91.
47. MADDEN PA, HEATH AC, PEDERSEN NL et al. The genetics of smoking persistence in men and women : a multicultural study. Behav Genet 1999 ; 29 (6) : 423-31.
48. MAES HH, WOODARD CE, MURRELLE L et al. Tobacco, alcohol and drug use in eight- to sixteen- year old twins : the Virginia study of adolescent behavioral developpement. J Stud Alc 1999 ; 60 (3) : 293-305.
49. MANSVELDER HD, MCGEHEE DS. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002 ; 53 (4) : 606-17.
50. MEDLUND P, CEDERLOF R, FLODERUS-MYRHED R. A new Swedish twin registry. Acta Med Scan 1977 (Suppl 60) : S20-S28.
51. MICHELHAUGH SK, FISKERSTRAND C, LOVEJOY E et al. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 2001 ; 79 : 1033-8.
52. NISELL M, NOMIKOS GG, SVENSSON TH. Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 1995 ; 76 : 157-62.
53. NIU T, CHEN C, NI J et al. Nicotine dependance and its familial aggregation in chinese. Int J Epidemiol 2000 ; 29 : 248-52.
54. NOBLE EP, BLUM K, RITCHIE T et al. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991 ; 48 (7) : 648-54.
55. OSCARSON M, MC LELLAN RA, GULLSTEN H et al. Characterization and PCR-based detection of a CYP2A6 gene deletion found at a high frequency in a Chinese population. FEBS Lett 1999 ; 460 : 105-10.
56. OSLER M, HOLST C, PRESCOTT E et al. Influence of genes and family environnement on adult smoking behavior assesssed in a adoption study. Genet Epidemiol 2001 ; 21 (3) : 193-200.
57. PIANEZZA ML, SELLERS EM, TYNDALE RF. Nicotine metabolism defect reduces smoking. Nature 1998 ; 393 : 750.
58. POMERLEAU CS, POMERLEAU OF, FLESSLAND KA et al. Relationship of tridimensional personality questionnaire scores and smoking variables in female and male smokers. J Subst Abuse 1992 ; 4 : 143-54.
59. PONTIERI FE, TANDA G, ORZI F. Effects of nicotine on nucleus accumbens and similarity to those of addictive drugs. Nature 1996 ; 382 : 255-7.
60. RAASCHOU-NIELSEN E. Smoking habits in twins. Dan Med Bull 1960 ; 7 : 82-8.
61. RAO Y, HOFFMANN E, ZIA M et al. Duplications and defects in the CYP2A6 gene : identification, genotyping, and in vivo effects of smoking. Mol Pharmacol 2000 ; 58 : 747-55.
62. RIBEIRO EB, BETTIKER RL, BOGDANOV M et al. Effects of systemic nicotine on serotonin release in rat brain. Brain Res 1993 ; 621 : 311-8.
63. RISCH N. The genetic epidemiology of cancer : interpreting family and twin studies and their implication for molecular genetic approaches. Cancer Epidemiol Biomark Prev 2001 ; 10 : 733-41.
64. ROJAS N, KILLEN J, HAYDEL K et al. Nicotine dependance among adolescent smokers. Arch Pediatr Adolesc Med 1998 ; 152 : 151-6.
65. ROSE JE, CORRIGALL WA. Nicotine self administration in animals and human : similarities and differences. Psychopharmacology (Berl) 1997 ; 130 : 28-40.
66. SAARISKOSKI ST, SATA F, HUSGAFVEL-PURSIAINEN K et al. CYP2D6 ultrarapid metaboliser genotype as a potential modifier of smoking behaviour. Pharmacogenetics 2000 ; 10 : 5-10.
67. SABOL SZ, NELSON ML, FISCHER C et al. A genetic association for cigarette smoking behaviour. Health Psychol 1999, 18 : 7-13.
68. SALOKANGAS RK, VILKMAN H, ILONEN T. High levels of dopamine activity in the basal ganglia of cigarette smokers. Am J Psychiatry 2000 ; 157 : 632-4.
69. SHIELDS PG, LERMAN C, AUDRAIN J et al. Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomark Prev 1998 ; 7 : 453-8.
70. SHIFFMAN S, JOHNSTON JA, KHAYRALLAH M et al. The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berl) 2000 ; 148 (1) : 33-40.
71. SPITZ MR, SHI H, YANG F et al. Case control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998 ; 90 : 358-63.
72. STEIN EA, PANKIEWICZ J, HARSCH HH. Nicotine-induced limbic cortical activation in the human brain : a functional MRI study. Am J Psychiatry 1998 ; 155 : 1009-15.
73. STEINLEIN O, WEILAND S, STOODT J et al. Exon-intron structure of the human neuronal nicotinic acetylcholine receptor alpha 4 subunit (CHRNA4). Genomics 1996 ; 32 (2) : 289-94.
74. STRAUB RE, SULLIVAN PF, MA Y et al. Susceptibility genes for nicotine dependence : a genome scan and follow-up in an independent sample suggest that regions on chromosome 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiarty 1999 ; 4 : 129-44.
75. SULLIVAN PF, KENDLER. The genetic epidemiology of smoking. Nicot Tobac Res 1999 (Suppl 2) : S51-7.
76. SULLIVAN PF, NEALE MC, SILVERMAN MA et al. An association study of DRD5 with smoking initiation and progression to nicotine dependence. Am J Med Genet 2001 ; 105 : 259-65.
77. SWAN GE, CARMELLI D, CARDON LR. Heavy consumption of cigarettes, alcohol and coffee in male twins. J Stud Alcohol 1997 ; 58 (2) : 182-90.
78. TODD RD, LOBOS EA, SUN LW et al. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder : evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry 2003 ; 8 (1) : 103-8.
79. TRICKER AR. Nicotine metabolism, human drug metabolism polymorphisms, and smoking behaviour. Toxicology 2003 ; 183 (1-3) : 151-73.
80. TRUE WR, HEATH AC, SCHERRER JF et al. Genetic and environnemental contributions to smoking. Addiction 1997 ; 92 : 1277-87.
81. TRUE WR, XIAN H, SCHERRER JF et al. Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 1999 ; 56 : 655-61.
82. TURGEON J, LABBÉ L, LEFEZ C et al. Desibroquine metabolic ratio distribution differs among smokers and non-smokers. Clin Pharmacol Ther 1995 ; 57 : 150.
83. TYNDALE RF. Genetics of alcohol and tobacco use in humans. Ann Med 2003 ; 35 : 94-121.
84. YOKOI T, KAMATAKI T. Genetic polymorphism of drug metabolising enzymes : new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm Res 1998 ; 15 : 517-24.
85. YUDKIN P, MUNAFO M, HEY K et al. Effectiveness of nicotine patches in relation to genotype in women versus men : randomised control trial. Br Med J 2004 ; 328 : 989-90.